Sit Investment Associates’s Idexx Laboratories IDXX Stock Holding History

Sit Investment Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29M	Hold	4,350	–	–	0.04%	287
2026 Q1	$2.44M	Hold	4,350	–	–	0.05%	274
2025 Q4	$2.94M	Hold	4,350	–	–	0.06%	264
2025 Q3	$2.78M	Sell	4,350 -1,150	-21%	-$698K	0.06%	272
2025 Q2	$2.95M	Hold	5,500	–	–	0.06%	269
2025 Q1	$2.31M	Buy	+5,500	New	+$2.39M	0.05%	293
2015 Q1	–	Sell	-12,000	Closed	-$890K	–	440
2014 Q4	$890K	Sell	12,000 -2,600	-18%	-$182K	0.01%	323
2014 Q3	$860K	Sell	14,600 -4,600	-24%	-$291K	0.02%	335
2014 Q2	$1.28M	Sell	19,200 -7,600	-28%	-$483K	0.02%	320
2014 Q1	$1.63M	Hold	26,800	–	–	0.03%	311
2013 Q4	$1.43M	Hold	26,800	–	–	0.03%	323
2013 Q3	$1.33M	Hold	26,800	–	–	0.03%	311
2013 Q2	$1.2M	Buy	+26,800	New	+$1.17M	0.02%	315

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sit Investment Associates's IDXX Position: Q2 2026 in Review

Sit Investment Associates held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 4,350 shares worth $2.29M. The position accounts for 0.04% of the portfolio, ranked #287.

Sit Investment Associates first reported a position in IDXX in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.95M in Q2 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Sit Investment Associates held 4,350 shares of Idexx Laboratories worth $2.29M as of Q2 2026.
Sit Investment Associates left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.04% of Sit Investment Associates's portfolio in Q2 2026, its #287 holding.
Sit Investment Associates first reported a position in Idexx Laboratories in Q2 2013 and has held it in 13 quarters since.
Sit Investment Associates's Idexx Laboratories position peaked at $2.95M in Q2 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.